These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value. de Reijke TM, de Boer EC, Kurth KH, Schamhart DH. J Urol; 1996 Feb; 155(2):477-82. PubMed ID: 8558640 [Abstract] [Full Text] [Related]
4. Systemic and local immunomodulatory effects of intravesical BCG therapy in patients with superficial urinary bladder carcinomas. Elsässer-Beile U, Gutzeit O, Bauer S, Katzenwadel A, Schultze-Seemann W, Wetterauer U. J Urol; 2000 Jan; 163(1):296-9. PubMed ID: 10604379 [Abstract] [Full Text] [Related]
5. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Cao Z, Baguley BC, Ching LM. Cancer Res; 2001 Feb 15; 61(4):1517-21. PubMed ID: 11245459 [Abstract] [Full Text] [Related]
6. Inhibition of fibronectin-activated migration of microvascular endothelial cells by interleukin-1alpha, tumour necrosis factor alpha and interferon gamma. Maier JA, Morelli D, Lazzerini D, Mènard S, Colnaghi MI, Balsari A. Cytokine; 1999 Feb 15; 11(2):134-9. PubMed ID: 10089134 [Abstract] [Full Text] [Related]
7. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy. Shintani Y, Sawada Y, Inagaki T, Kohjimoto Y, Uekado Y, Shinka T. Int J Urol; 2007 Feb 15; 14(2):140-6. PubMed ID: 17302571 [Abstract] [Full Text] [Related]
8. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. Salvucci O, Basik M, Yao L, Bianchi R, Tosato G. J Leukoc Biol; 2004 Jul 15; 76(1):217-26. PubMed ID: 15075355 [Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Ramakrishnan S, Olson TA, Bautch VL, Mohanraj D. Cancer Res; 1996 Mar 15; 56(6):1324-30. PubMed ID: 8640821 [Abstract] [Full Text] [Related]
10. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM. Medicina (B Aires); 2000 Mar 15; 60 Suppl 2():41-7. PubMed ID: 11188930 [Abstract] [Full Text] [Related]
11. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Richard L, Velasco P, Detmar M. Exp Cell Res; 1998 Apr 10; 240(1):1-6. PubMed ID: 9570915 [Abstract] [Full Text] [Related]
12. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ. Invest Ophthalmol Vis Sci; 2002 Mar 10; 43(3):821-9. PubMed ID: 11867604 [Abstract] [Full Text] [Related]
13. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells. Sakamoto T, Ishibashi T, Kimura H, Yoshikawa H, Spee C, Harris MS, Hinton DR, Ryan SJ. Invest Ophthalmol Vis Sci; 1995 May 10; 36(6):1076-83. PubMed ID: 7537258 [Abstract] [Full Text] [Related]
14. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ. Clin Cancer Res; 2000 Mar 10; 6(3):957-65. PubMed ID: 10741721 [Abstract] [Full Text] [Related]
15. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. Watanabe Y, Dvorak HF. Exp Cell Res; 1997 Jun 15; 233(2):340-9. PubMed ID: 9194496 [Abstract] [Full Text] [Related]
16. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T. Circ Res; 2003 Sep 05; 93(5):438-47. PubMed ID: 12881481 [Abstract] [Full Text] [Related]
17. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Jia H, Jezequel S, Löhr M, Shaikh S, Davis D, Soker S, Selwood D, Zachary I. Biochem Biophys Res Commun; 2001 Apr 27; 283(1):164-73. PubMed ID: 11322784 [Abstract] [Full Text] [Related]
18. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Nör JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ. Cancer Res; 2001 Mar 01; 61(5):2183-8. PubMed ID: 11280784 [Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K. J Cell Physiol; 1998 Dec 01; 177(3):439-52. PubMed ID: 9808152 [Abstract] [Full Text] [Related]
20. Cytokine gene expression in a mouse model: the first instillations with viable bacillus Calmette-Guerin determine the succeeding Th1 response. De Boer EC, Rooijakkers SJ, Schamhart DH, Kurth KH. J Urol; 2003 Nov 01; 170(5):2004-8. PubMed ID: 14532842 [Abstract] [Full Text] [Related] Page: [Next] [New Search]